Literature DB >> 32531590

Prevalence and transmission of antimicrobial-resistant Staphylococci and Enterococci from shared bicycles in Chengdu, China.

Ju Gu1, Xian-Jun Xie1, Jin-Xin Liu2, Jun-Rui Shui1, Hao-Yu Zhang1, Gan-Yu Feng1, Xiao-Yu Liu1, Lin-Can Li1, Qi-Wei Lan1, Qi-Han Jin1, Rui Li1, Li Peng1, Chang-Wei Lei1, An-Yun Zhang3.   

Abstract

Shared bicycles are prevailing in China but the extent to which they contribute to maintaining and transmitting pathogens and antibiotic-resistant bacteria remain largely unknown. To fill the knowledge gap, herein, swab samples (n = 963) were collected from handlebars of shared bicycles in areas of hospital, school, metro station (n = 887) and riders (n = 76) in Chengdu, China. Staphylococci (n = 241) and Enterococci (n = 69) were widely distributed across sampling locations at a frequency of 2.3%-12.9%, and 0.08%-5.5%, respectively. Bicycle or rider-borne Gram-positive bacteria were frequently resistant to clinically important antibiotics including linezolid, fosfomycin, and vancomycin, and a significant portion of these isolates (3.4%-16.6% for Staphylococci and 0.1%-13.8% for Enterococci) indicated multidrug resistance. Nineteen Staphylococcus aureus isolates were identified in this collection and 52.6% of which were considered as methicillin-resistant S. aureus. Whole genome sequencing further characterized 26 antimicrobial resistance genes (ARGs) including fosB, fusB, and lnu(G) in S. aureus and 21 ARGs including optrA in Enterococci. Leveraging a complementary approach with conventional MLST, whole genome SNP and MLST analyses, we present that genetically closely-related bacteria were found in bicycles and riders across geographical-distinct locations suggesting bacterial transmission. Further, five new ST types 5697-5701 were firstly characterized in S. aureus. ST 942 and ST 1640 are new ST types observed in E. faecalis, and E. faecium, respectively. Our results highlighted the risk of shared bicycle system in disseminating pathogens and antibiotic resistance which warrants effective disinfections.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Environmental contamination; Public transportation; Shared bicycle

Mesh:

Substances:

Year:  2020        PMID: 32531590     DOI: 10.1016/j.scitotenv.2020.139735

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

Review 1.  The Bacterial Urban Resistome: Recent Advances.

Authors:  Alberto Vassallo; Steve Kett; Diane Purchase; Massimiliano Marvasi
Journal:  Antibiotics (Basel)       Date:  2022-04-12

2.  Prevalence and Molecular Characterization of Methicillin-Resistant Staphylococci Recovered from Public Shared Bicycles in China.

Authors:  Zhen Xu; Liqin Chen; Xiaowei Chen; Amei Tang; Dengmin Huang; Qin Pan; Zhongze Fang
Journal:  Int J Environ Res Public Health       Date:  2022-04-08       Impact factor: 4.614

3.  Characterization of blaNDM-5-and blaCTX-M-199-Producing ST167 Escherichia coli Isolated from Shared Bikes.

Authors:  Qiyan Chen; Zhiyu Zou; Chang Cai; Hui Li; Yang Wang; Lei Lei; Bing Shao
Journal:  Antibiotics (Basel)       Date:  2022-07-30

4.  Characteristics and Outcomes of Shared Bicycle-Related Injuries from a Large Emergency Medical Centre in China, 2017-2021.

Authors:  Mao Chen; Weiwei Li; Jun Ye; Gang Liu; Chaolin Huang
Journal:  Emerg Med Int       Date:  2022-06-22       Impact factor: 1.621

5.  The Role of Whole Genome Sequencing in the Surveillance of Antimicrobial Resistant Enterococcus spp.: A Scoping Review.

Authors:  Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley
Journal:  Front Public Health       Date:  2021-06-10

6.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.